ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1219

Gender-Related Clinical Profile of Fibromyalgia Patients

Mark Berman1, Liane banon2, Omer Shlezinger3, Laurence Mangel4, Jacob Ablin1 and Valerie Aloush5, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Gastroenterology and Hepatolgy, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Internal Medicine F, Tel Aviv, Israel, 4Sackler faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 5Tel Aviv Medical Center, Tel Aviv, Israel

Meeting: ACR Convergence 2022

Keywords: fibromyalgia, gender

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Fibromyalgia is a chronic pain disorder characterized by widespread pain, fatigue, sleep disturbances, cognitive dysfunction and frequent psychiatric comorbidities. Estimated prevalence of fibromyalgia is 1-5%, with an estimated female to male ratio of 3-6:1. The influence of gender on epidemiologic and clinical characteristics as well as on therapeutic strategies of fibromyalgia patients is still incompletely understood. In the current study, we aimed to describe the clinical and epidemiologic profile of male compared with female fibromyalgia patients, in a real-word cohort.

Methods: We conducted a retrospective cross-sectional observational study, including all patients diagnosed with fibromyalgia in the electronic medical record database of a tertiary hospital during the period 2010-2021. Patient files were subsequently screened individually, and data was collected, including sociodemographic characteristics, medical and psychiatric diagnoses, and treatment regimens, including use of medical cannabis.

Results: Altogether, we found 3044 patients diagnosed with fibromyalgia, 401of them were male (13.2%). Most of the patients (84%) were followed up at the Rheumatology Institute and 16% at the Pain Clinic. We subsequently created a random cohort of 438 female patients and compared it to the male cohort. The mean age of female patients was significantly higher than that of males (52.7 years versus 44.9, p< 0.001). Obesity was significantly more prevalent among female patients than among male patients (16% versus 9.2% respectively, p= 0.003), whereas Obstructive Sleep Apnea Syndrome was more prevalent in males (6.7% versus 1.8%, p< 0.001). Male patients had a significantly higher prevalence of Post-Traumatic Stress Disorder (PTSD) compared with females (14% versus 5.7%, p< 0.001). No significant differences were observed in other psychiatric comorbidities such as depression and anxiety. Only three male patients had a documented diagnosis of erectile dysfunction. Females were more frequently treated by Amitriptyline and Tramadol. There were no differences in the use of Pregabalin or Duloxetine between males and females. Almost half of the male patients (48%) were treated with medical cannabis compared with 34.6% of females (p< 0.001). A significant correlation was observed between a diagnosis of PTSD and the use of medical cannabis in both genders.

Conclusion: Significant clinical gender-specific characteristics were observed in our real-world cohort of fibromyalgia patients.

PTSD and use of medical cannabis appeared to be significantly more common among male patients while obesity was more common among females. Further research into the clinical and pathogenetic mechanisms underlying these differences are warranted.


Disclosures: M. Berman, None; L. banon, None; O. Shlezinger, None; L. Mangel, None; J. Ablin, None; V. Aloush, None.

To cite this abstract in AMA style:

Berman M, banon L, Shlezinger O, Mangel L, Ablin J, Aloush V. Gender-Related Clinical Profile of Fibromyalgia Patients [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/gender-related-clinical-profile-of-fibromyalgia-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gender-related-clinical-profile-of-fibromyalgia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology